Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariano Galdiero

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Muscles, Ligaments and Tendons Journal|December 10, 2014
Cushing, acromegaly, GH deficiency and tendonsMariano Galdiero, Renata S Auriemma, Rosario Pivonello, et al.
Reviews in Endocrine & Metabolic Disorders|December 29, 2007
Medical consequences of acromegaly: what are the effects of biochemical control?Annamaria Colao, Renata S Auriemma, Rosario Pivonello, et al.
Neuroendocrinology|October 19, 2006
Acromegaly and the cardiovascular systemGaetano Lombardi, Mariano Galdiero, Renata S Auriemma, et al.
The Journal of Clinical Endocrinology and Metabolism|July 23, 2009
Effects of initial therapy for five years with somatostatin analogs for acromegaly on growth hormone and insulin-like growth factor-I levels, tumor shrinkage, and cardiovascular disease: a prospective studyAnnamaria Colao, Renata S Auriemma, Mariano Galdiero, et al.
European Journal of Endocrinology|November 7, 2007
Beneficial effect of dose escalation of octreotide-LAR as first-line therapy in patients with acromegalyAnnamaria Colao, Rosario Pivonello, Renata S Auriemma, et al.
European Journal of Endocrinology|August 27, 2011
Determinants of cardiac disease in newly diagnosed patients with acromegaly: results of a 10 year survey studyAnnamaria Colao, Rosario Pivonello, Ludovica Francesca Stella Grasso, et al.
The Journal of Clinical Endocrinology and Metabolism|June 4, 2009
Glucose tolerance and somatostatin analog treatment in acromegaly: a 12-month studyAnnamaria Colao, Renata S Auriemma, Silvia Savastano, et al.
The Journal of Clinical Endocrinology and Metabolism|July 27, 2007
The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patientsAnnamaria Colao, Rosario Pivonello, Renata S Auriemma, et al.
The Journal of Clinical Endocrinology and Metabolism|July 3, 2008
Growth hormone-secreting tumor shrinkage after 3 months of octreotide-long-acting release therapy predicts the response at 12 monthsAnnamaria Colao, Rosario Pivonello, Renata S Auriemma, et al.
Clinical Endocrinology|December 20, 2008
Significant tumour shrinkage after 12 months of lanreotide Autogel-120 mg treatment given first-line in acromegalyAnnamaria Colao, Renata S Auriemma, Alberto Rebora, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Muscles, Ligaments and Tendons Journal|December 10, 2014
Cushing, acromegaly, GH deficiency and tendonsMariano Galdiero, Renata S Auriemma, Rosario Pivonello, et al.
Reviews in Endocrine & Metabolic Disorders|December 29, 2007
Medical consequences of acromegaly: what are the effects of biochemical control?Annamaria Colao, Renata S Auriemma, Rosario Pivonello, et al.
Neuroendocrinology|October 19, 2006
Acromegaly and the cardiovascular systemGaetano Lombardi, Mariano Galdiero, Renata S Auriemma, et al.
The Journal of Clinical Endocrinology and Metabolism|July 23, 2009
Effects of initial therapy for five years with somatostatin analogs for acromegaly on growth hormone and insulin-like growth factor-I levels, tumor shrinkage, and cardiovascular disease: a prospective studyAnnamaria Colao, Renata S Auriemma, Mariano Galdiero, et al.
European Journal of Endocrinology|November 7, 2007
Beneficial effect of dose escalation of octreotide-LAR as first-line therapy in patients with acromegalyAnnamaria Colao, Rosario Pivonello, Renata S Auriemma, et al.
European Journal of Endocrinology|August 27, 2011
Determinants of cardiac disease in newly diagnosed patients with acromegaly: results of a 10 year survey studyAnnamaria Colao, Rosario Pivonello, Ludovica Francesca Stella Grasso, et al.
The Journal of Clinical Endocrinology and Metabolism|June 4, 2009
Glucose tolerance and somatostatin analog treatment in acromegaly: a 12-month studyAnnamaria Colao, Renata S Auriemma, Silvia Savastano, et al.
The Journal of Clinical Endocrinology and Metabolism|July 27, 2007
The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patientsAnnamaria Colao, Rosario Pivonello, Renata S Auriemma, et al.
The Journal of Clinical Endocrinology and Metabolism|July 3, 2008
Growth hormone-secreting tumor shrinkage after 3 months of octreotide-long-acting release therapy predicts the response at 12 monthsAnnamaria Colao, Rosario Pivonello, Renata S Auriemma, et al.
Clinical Endocrinology|December 20, 2008
Significant tumour shrinkage after 12 months of lanreotide Autogel-120 mg treatment given first-line in acromegalyAnnamaria Colao, Renata S Auriemma, Alberto Rebora, et al.
Pageof 3